Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural and hemp products and other biotech products, announced that it entered into a framework agreement (the “Framework Agreement”) on October 4, 2021, to acquire over 51% equity interest of Beijing Wonner Biotech Co., Ltd. (“Beijing Wonner”) with no more than $30 million, to jointly develop SNG, a rapid-acting antidepressant natural innovative medicine.
October 5, 2021
· 5 min read